Long-Term Follow up of 90y-Ibritumomab Tiuxetan, Fluadarabine and TBI Based Non-Myeloablative Allogeneic Transplant Conditioning for Persistent High-Risk B-Cell Lymphoma

Authors
Publication date
1 January 2017
Publisher
'United States Sports Academy'

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    Sustaining member

    University of Miami: Scholarship Miami

    redirect
    oaioai:alma.01UOML_INST:114355240...
    Last time updated on 03/05/2024